Spain · AEMPS CIMA
ESTALIS SEQUIDOT PARCHE TRANSDERMICO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69746
- Form
- PARCHE TRANSDÉRMICO
- Composition / generic term
- noretisterona + estradiol
- Source strength
- 50 MCG ESTRADIOL / 50 MCG ESTRADIOL+250 MCG NORETI
- Authorisation holder
- Bexal Farmaceutica S.A.
- Marketed in source snapshot
- No
Source-listed ingredients
- ESTRADIOL HEMIHIDRATO — 0,78 mg
- ESTRADIOL HEMIHIDRATO — 0,512 mg
- NORETISTERONA ACETATO — 4,80 mg
These values do not establish equivalence or a dose recommendation.
Packages
- ESTALIS SEQUIDOT PARCHE TRANSDERMICO , 8 parches
Source and coverage
Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Spain records →